Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Is dopamine involved in Alzheimer's disease?”
Alessandro Martorana, Giacomo Koch
Frontiers in Aging Neuroscience (2014) Vol. 6
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Alzheimer's disease: Targeting the Cholinergic System
Talita H. Ferreira‐Vieira, Isabella G. Olmo, Flávia Rodrigues da Silva, et al.
Current Neuropharmacology (2016) Vol. 14, Iss. 1, pp. 101-115
Open Access | Times Cited: 1270
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih, Tong Chen, Alistair V.W. Nunn, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 699-730
Open Access | Times Cited: 499
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease
Annalisa Nobili, Emanuele Claudio Latagliata, Maria Teresa Viscomi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 410
Social brain, social dysfunction and social withdrawal
Stefano Porcelli, Nic J.A. van der Wee, Steven van der Werff, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 97, pp. 10-33
Open Access | Times Cited: 317
Management of oxidative stress and other pathologies in Alzheimer’s disease
Miriama Šimunková, Saleh Alwasel, Ibrahim M. Alhazza, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 9, pp. 2491-2513
Open Access | Times Cited: 230
Application of Metabolomics in Alzheimer’s Disease
Jordan Wilkins, Eugenia Trushina
Frontiers in Neurology (2018) Vol. 8
Open Access | Times Cited: 222
Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 20, pp. 6512-6527
Closed Access | Times Cited: 215
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
Marie Jouanne, Sylvain Rault, Anne Sophie Voisin‐Chiret
European Journal of Medicinal Chemistry (2017) Vol. 139, pp. 153-167
Closed Access | Times Cited: 206
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 114
The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators
Lilin Chen, Yonggang Fan, Lingxiao Zhao, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106301-106301
Closed Access | Times Cited: 110
Alzheimer's and Parkinson's disease therapies in the clinic
Puja Chopade, Neha Chopade, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 95
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease
Lan Guo, Jing Tian, Heng Du
Journal of Alzheimer s Disease (2016) Vol. 57, Iss. 4, pp. 1071-1086
Open Access | Times Cited: 167
Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease
Kushal Kumar, Ashwani Kumar, Richard M. Keegan, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 98, pp. 297-307
Closed Access | Times Cited: 135
Dopaminergic Regulation of Innate Immunity: a Review
Monica Pinoli, Franca Marino, Marco Cosentino
Journal of Neuroimmune Pharmacology (2017) Vol. 12, Iss. 4, pp. 602-623
Closed Access | Times Cited: 123
Dopamine Autoxidation Is Controlled by Acidic pH
Nejc Umek, Blaž Geršak, Neli Vintar, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 106
Toxoplasmosis: A pathway to neuropsychiatric disorders
Shiraz Tyebji, Simona Seizova, Anthony J. Hannan, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 96, pp. 72-92
Closed Access | Times Cited: 97
Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress
Saida Haider, Laraib Liaquat, Saara Ahmad, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0227631-e0227631
Open Access | Times Cited: 97
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
Kunal Dhiman, Kaj Blennow, Henrik Zetterberg, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 10, pp. 1833-1863
Open Access | Times Cited: 90
Electrochemical detection of dopamine with negligible interference from ascorbic and uric acid by means of reduced graphene oxide and metals-NPs based electrodes
Bernardo Patella, Alessia Sortino, Francesca Mazzara, et al.
Analytica Chimica Acta (2021) Vol. 1187, pp. 339124-339124
Open Access | Times Cited: 77
Toward noninvasive brain stimulation 2.0 in Alzheimer’s disease
Arianna Menardi, Símone Rossi, Giacomo Koch, et al.
Ageing Research Reviews (2021) Vol. 75, pp. 101555-101555
Open Access | Times Cited: 71
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease
Livia La Barbera, Francescangelo Vedele, Annalisa Nobili, et al.
Progress in Neurobiology (2021) Vol. 202, pp. 102031-102031
Open Access | Times Cited: 69
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Elena Possemato, Livia La Barbera, Annalisa Nobili, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101907-101907
Closed Access | Times Cited: 39
Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection
Yunyun Huang, Pengwei Chen, Luyan Zhou, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 25
A new perspective on positive symptoms: expression of damage or self-defence mechanism of the brain?
Annibale Antonioni, Emanuela Maria Raho, Mariachiara Sensi, et al.
Neurological Sciences (2024) Vol. 45, Iss. 5, pp. 2347-2351
Open Access | Times Cited: 12
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
K. Kawahata, David I. Finkelstein, Kohji Fukunaga
Receptors (2024) Vol. 3, Iss. 2, pp. 155-181
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top